TCG Crossover Management »

Aura Biosciences shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $68M 9.5M 7.10

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Aura Biosciences

TCG Crossover Management
Suvretta Capital Management
Frazier Life Sciences Management
Long Focus Capital Management
Adage Capital Partners GP
Caligan Partners
Vanguard Capital Management
BlackRock
OrbiMed Advisors
Medicxi Ventures Management
Nantahala Capital Management
Jupiter Topco
RA Capital Management
Balyasny Asset Management
Franklin Resources

View all funds holding Aura Biosciences